• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

17.13 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
January 07, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 26, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Provides Notice of Proposed Derivative Settlement
December 18, 2025
From CareDx, Inc.
Via Business Wire
News headline image
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
November 24, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in Upcoming Investor Conferences
November 10, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 07, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025
November 06, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Third Quarter 2025 Financial Results
November 04, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer
October 27, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure
October 23, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
October 22, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
October 21, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting
October 06, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Issues Comment Letter on Draft LCD Policy
September 02, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Participate in Wells Fargo Healthcare Conference
August 21, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
August 06, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Second Quarter 2025 Financial Results
August 06, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation
August 06, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress
July 31, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report Second Quarter 2025 Financial Results
July 23, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection
July 18, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Repurchase of 5% of Outstanding Shares
June 03, 2025
From CareDx, Inc.
Via Business Wire
News headline image
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
May 22, 2025
From Johnson Fistel, PLLP
Via Business Wire
News headline image
CareDx to Participate in Upcoming Investor Conferences
May 13, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reports First Quarter 2025 Results
April 30, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting
April 29, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting
April 24, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
April 21, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CareDx to Report First Quarter 2025 Financial Results
April 08, 2025
From CareDx, Inc.
Via Business Wire
News headline image
CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA
March 28, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap